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 Over several millions of years of evolution, mitochondria have transformed into spe-
cialized organelles. Today, they cannot live outside the cell nor can the host cell live without 
them, resulting in a symbiotic relationship. Richard Altmann, in 1894, documented them as 
cell organelles and called them “bioblasts”. Later, the term “mitochondria” itself was coined 
by Carl Benda in 1898. Ever since these findings, we in the field of medicine have learned a 
lot about this tiny organelle, but numerous aspects continue to be discovered. In this article, we 
will review the significance of this organelle in terms of pancreatic dysfunctions. 
 Mitochondria are a double membrane organelle and are often considered to be “the 
powerhouse of the cell.” This organelle is extremely important to the maintenance of vital 
biological processes such as the Krebs cycle, Tricarboxylic acid (TCA) cycle, the generation 
of Adenosine Triphosphate (ATP) (the body’s main energy source), signal transduction, cell 
growth, cell death and much more. Due to the many roles that the mitochondrion plays in these 
biological processes, it is evident that any type of mitochondrial dysfunction would result in a 
myriad of diseases. Over the past decade, we have become aware of several clinical syndromes 
that might be associated with mitochondrial DNA (mt-DNA) mutations. The increasing rec-
ognition of mt-DNA involvement in disease is partially due to the relative ease of sequencing 
the mitochondrial genome.1 Mitochondrial DNA (mt-DNA) carries only 37 genes that encode 
13 polypeptides, 22 transfer RNAs (tRNAs) and 2 ribosomal RNAs (rRNAs).2 A number of 
the common diseases that have shown to have possible mt-DNA variations are Alzheimer’s 
disease, Parkinson’s disease and diabetes. The associations of these diseases with mt-DNA mu-
tations have encouraged a large number of studies.1 The mitochondrial electron transport chain 
is an important site of Reactive Oxygen Species (ROS) production within the cell. Despite 
intracellular protective mechanisms, including superoxide dismutase, catalase and reduced glu-
tathione, excess ROS is detrimental to cellular physiology.3 Aging, defined as an irreversible 
decline in physiologic function overtime, is also characterized by mitochondrial dysfunctions. 
Neurons are also known to be vulnerable to mitochondrial dysfunction, synaptic regions of ax-
ons are known to contain abundant mitochondria, thus suggesting that mitochondrial dysfunc-
tion may play a key role in many neurological diseases such as Parkinson’s and Alzheimer’s 
disease.4 Current research is starting to highlight the relationship of mitochondrial dysfunction 
with a multitude of diseases. The pancreas is one such organ where more research is necessary 
to identify possible treatments for mitochondrial related ailments. Already, pancreatitis, diabe-
tes, and pancreatic cancer have shown a connection with mitochondrial dysfunction to certain 
subgroups of these diseases.
 Diabetes may be one of the most studied diseases when it comes to mitochondrial dys-
function related to pancreatic issues. Diabetes includes a wide group of conditions that overall 
cause hyperglycemia.5 Recent research has shown mutations in mt-DNA can be related to dia-
betes. Wang, et al. suggested that the mitochondrial gene tRNA(Leu (UUR)) 3243 A to G mutation 
is a potential risk factor in developing diabetes.6 Along with mitochondrial dysfunction leading 
to diabetes, problems in the mitochondria have also been shown to lead to pathologic changes 
caused by diabetes. For example, diabetic retinopathy is one of the hallmarks of progressive 







Mitochondrial ROS is increased in the retina, which impairs mt-
DNA.7 Also, Transcription Factor A Mitochondrial (TFAM) is 
a key regulator of the transcription of mt-DNA.7 Santos, et al. 
have shown that ubiquitination of TFAM in diabetes prevents 
its transport to the mitochondria, which disrupts mitochondrial 
homeostasis indicating the strong relation with diabetes and mi-
tochondrial dysfunction.7
 Kearns-Sayre Syndrome (KSS) is a rare cause of diabe-
tes in children. KSS has a group of diseases, known as the classic 
triad, which includes retinitis pigmentosa, progressive external 
ophthalmoplegia, and cardiac conduction problems.8 Mitochon-
dria Deoxyribonucleic acid (DNA) deletions have been shown 
to be abnormal in pancreatic islet cells in patients with KSS. 
Surprisingly, insulin receptor abnormalities do not appear to 
contribute to the development of diabetes in KSS, further high-
lighting the role of mitochondrial dysfunction.8 Another rare 
mitochondria disorder that can cause diabetes is Pearson Mar-
row Pancreas Syndrome (PMPS). This disorder is caused by im-
paired mitochondrial respiratory chain complexes, although the 
specific mutations may differ among individuals with PMPS.9
 
 Unfortunately, compared to diabetes, research on mi-
tochondria related dysfunction to pancreatitis has been thus far 
extremely limited. However, from what has been published, 
it has been demonstrated that mitochondrial irregularities can 
be linked to pancreatitis. Pancreatitis is often described as an 
inflammation of the pancreas and can represent as an acute or 
chronic form.10 Recent studies have shown mitochondrial dam-
age leading to ATP depletion as a common factor related to acute 
pancreatitis. Also, the generation of ROS is another major cause 
of acute pancreatitis.11
 
 Similar to pancreatitis, there has not been enough re-
search on the relation between mitochondrial dysfunction and 
pancreatic cancer. However, there has been an increase in un-
derstanding the possible involvements of mitochondria in pan-
creatic cancers.12 It has been shown that pancreatic cancer cells 
have a greater density of mitochondria, which could be used as a 
potential diagnostic marker.13 Mathematic modeling has shown 
that perhaps a random mutation in the mt-DNA can cause homo-
plasmy among mitochondria in pancreatic cancer cells, which in 
turn can lead to an increase in dysfunctional mitochondria in the 
cancer cells.13 
 In conclusion, this review supports that many human 
ailments including diabetes, pancreatitis and pancreatic cancers 
are in part, due to faulty mitochondrial function. Hence, it is 
necessary to understand the nature of mitochondrial involve-
ment in pancreatic dysfunction for proper treatment regimens. 
It has been over 100 years since Richard Altmann’s discovery of 
mitochondria and we continue to learn new things today. With 
this, we wish the Pancreas - Open Journal all the success in their 
endeavor; and we hope that future researches related to mito-
chondrial dysfunction and pancreatic ailments will be discussed 
in this Journal dedicated to the pancreas. 
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